Software That Treats
Digital therapeutics (DTx) represent a distinct category within digital health: software applications that deliver evidence-based therapeutic interventions to prevent, manage, or treat medical conditions, validated through clinical trials and, in some cases, cleared by regulators. Unlike general wellness apps, prescription digital therapeutics undergo rigorous testing and are used under clinical guidance. They embody the idea that a well-designed program delivered through software can itself be a treatment, not merely a tool.
Where They Show Promise
Digital therapeutics have shown particular promise in areas where behavior and cognition are central. Programs delivering cognitive behavioral therapy for insomnia, anxiety, and depression have demonstrated efficacy in trials, extending access to evidence-based psychotherapy that is often scarce. DTx for substance use disorders, chronic disease management like diabetes, and certain neurological conditions have received regulatory clearance. Their scalability could address gaps where trained providers are limited, delivering consistent, evidence-based intervention.
Challenges to Adoption
Despite their promise, digital therapeutics face real hurdles. Reimbursement pathways remain unsettled, making it unclear how these products are paid for. Questions about long-term engagement — apps only work if used — and integration into clinical workflow persist. The evidence base, while growing, varies in quality across products. As payment models mature and evidence accumulates, digital therapeutics could become a standard component of care for suitable conditions, complementing traditional treatments with accessible, scalable interventions. Facilities can source patient care supplies and diagnostic equipment from our catalog.
